Demeetra AgBio Revenue and Competitors
Estimated Revenue & Valuation
- Demeetra AgBio's estimated annual revenue is currently $2M per year.
- Demeetra AgBio's estimated revenue per employee is $155,000
Employee Data
- Demeetra AgBio has 13 Employees.
- Demeetra AgBio grew their employee count by -13% last year.
Demeetra AgBio's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Director Gene Editing | Reveal Email/Phone |
3 | Manager- R&D Operations | Reveal Email/Phone |
4 | Scientific Business Development | Reveal Email/Phone |
5 | Scientific Business Development | Reveal Email/Phone |
6 | Controller | Reveal Email/Phone |
7 | Brand Ambassador | Reveal Email/Phone |
Demeetra AgBio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.4M | 9 | 50% | N/A | N/A |
#2 | $1.4M | 9 | 50% | N/A | N/A |
#3 | $2.6M | 17 | 0% | N/A | N/A |
#4 | $4.5M | 29 | 4% | N/A | N/A |
#5 | $609.3M | 3931 | 3% | N/A | N/A |
#6 | $0.8M | 5 | 0% | N/A | N/A |
#7 | $0.8M | 5 | 0% | N/A | N/A |
#8 | $5M | 32 | 23% | N/A | N/A |
#9 | $27.4M | 177 | -14% | N/A | N/A |
#10 | $1.7M | 11 | 0% | N/A | N/A |
What Is Demeetra AgBio?
Demeetra holds the exclusive licenses for research and commercial fields in agriculture, industrial biotech and pharmaceutical bioprocessing to the platform gene editing technologies, Cas-CLOVER (the clean CRISPR/Cas9 alternative) and piggyBac transposase. We license these technologies or partner under joint development agreements for applications in the engineering of crops and agricultural animals, plant-based drug development and enhanced bioprocessing in human & animal health. Through our technology platforms, expertise and partnerships we are focused on Engineering Traits for Life.
keywords:N/AN/A
Total Funding
13
Number of Employees
$2M
Revenue (est)
-13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2M | 13 | 8% | N/A |
#2 | $1M | 13 | -35% | $145M |
#3 | $1.8M | 13 | 44% | N/A |
#4 | $2M | 14 | 17% | N/A |
#5 | $2M | 14 | 8% | N/A |